Keith W Chan, MD
Orthopedic Surgery · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 22 years
- Stanford University School of Medicine, 2004
Offices
2 locations · California Pacific Orthopaedics and Sports Medicine A Medical Corporat · Regents of the University of California - UCSF
Hospitals listed: California Pacific Medical Center - Mission Bernal · Novato Community Hospital. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chan’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A106438 · Current
Licensed to practise in California · since 2009 · expires 2026-11-30 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Orthopaedic Surgery - Orthopaedic Surgery
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center - Mission BernalSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.322, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center - Mission Bernal
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 3 the same, 3 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.322 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.19 to 2.28) · 336 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.47 to 1.27) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 163.19 (101.27 to 225.11) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 44 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 155 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 177 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.6 · 32 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,281 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 2,912 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 2,681 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.07 (1.81 to 6.33) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 425 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.46 (0.79 to 4.12) · 755 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.36 (0 to 16.38) · 431 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.47 (1.38 to 9.55) · 401 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.2 to 3.2) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 1.16) · 2,291 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 2.4 · 369 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.602 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.618 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.9 · 197 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 39.6 · 203 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 292 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 353 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 74 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 110 cases | No different | Jan 2024 – Dec 2024 |
What patients said (406 patients answered, 18% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$45,337
Medicare paid this office $45,337 for 202 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 77 | $8,588 | $82 |
| Return visit (30+ min) | 37 | $4,287 | $113 |
| Aspiration and/or injection of fluid from large joint | 44 | $3,084 | $56 |
| New patient visit (45+ min) | 17 | $2,448 | $144 |
| New patient visit (30+ min) | 22 | $1,773 | $81 |
See all 11 services
| Short return visit (20+ min) | 77 | $8,588 | $82 |
| Return visit (30+ min) | 37 | $4,287 | $113 |
| Aspiration and/or injection of fluid from large joint | 44 | $3,084 | $56 |
| New patient visit (45+ min) | 17 | $2,448 | $144 |
| New patient visit (30+ min) | 22 | $1,773 | $81 |
| Mri scan of leg joint without contrast | 11 | $1,653 | $150 |
| X-ray of knee, 3 views | 25 | $942 | $36 |
| X-ray of hip, 2-3 views | 13 | $556 | $37 |
| Injection, methylprednisolone acetate, 1 mg | 56 | $406 | None |
| Injection, methylprednisolone acetate, 40 mg | 18 | $156 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 16 | $58 | None |
Procedures Medicare counted
| Hip replacement | 1-10 | None |
| Lower limb (leg) arthroscopy (minimally invasive joint repair) | 1-10 | None |
| Upper limb (arm) arthroscopy (minimally invasive joint repair) | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 83 | 55 | 108 | 111 | 72 | 55 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | – | – | 13 | 22 | 19 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
202 Original Medicare patients in 2024. Average age 72 · Women 57% · Also on Medicaid 10% · Health risk score 0.89. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 52% · Coronary heart disease 21% · Diabetes 14% · Cancer 13% · Atrial fibrillation 13% · Depression 12% · Chronic kidney disease 11% · Heart failure 9% · COPD 6%.
The office billed $205,692, Medicare allowed $61,265 and paid $45,337; for 5,816 services of 39 kinds; $6,860 of it was for drugs given in the office and $38,477 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 202 | 5,816 | 72 | 0.89 | $205,692 | $45,337 |
| 2023 | 223 | 2,276 | 73 | 0.77 | $295,255 | $66,497 |
| 2022 | 256 | 1,807 | 72 | 0.79 | $280,437 | $66,805 |
| 2021 | 243 | 963 | 73 | 0.87 | $268,458 | $72,910 |
| 2020 | 225 | 566 | 74 | 1.04 | $208,587 | $51,056 |
| 2019 | 343 | 859 | 74 | 1.11 | $267,011 | $68,433 |
| 2018 | 408 | 1,162 | 74 | 0.99 | $309,816 | $74,595 |
| 2017 | 407 | 1,242 | 74 | 1.11 | $337,295 | $84,216 |
| 2016 | 348 | 1,020 | 74 | 1.06 | $269,617 | $69,966 |
| 2015 | 269 | 839 | 73 | 1.03 | $296,350 | $73,311 |
| 2014 | 303 | 1,003 | 75 | 0.98 | $310,661 | $81,440 |
| 2013 | 303 | 1,264 | 74 | 1.07 | $303,540 | $69,813 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 31 | $10,416 | None |
| Short return visit (20+ min) | 81 | $9,294 | $79 |
| Return visit (30+ min) | 55 | $6,607 | $114 |
| Aspiration and/or injection of fluid from large joint | 60 | $4,171 | $58 |
| Mri scan of leg joint without contrast | 24 | $3,822 | $147 |
| New patient visit (30+ min) | 35 | $3,279 | $94 |
| New patient visit (45+ min) | 13 | $1,884 | $145 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 17 | $1,794 | $94 |
| Injection, methylprednisolone acetate, 40 mg | 68 | $994 | None |
| X-ray of knee, 3 views | 24 | $939 | $38 |
| X-ray of hip, 2-3 views | 19 | $937 | $45 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $79 | None |
2022: 12 services
| Short return visit (20+ min) | 141 | $15,305 | $74 |
| Aspiration and/or injection of fluid from large joint | 81 | $6,199 | $56 |
| Return visit (30+ min) | 44 | $5,211 | $111 |
| New patient visit (30+ min) | 56 | $4,801 | $86 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 18 | $4,337 | None |
| Mri scan of leg joint without contrast | 21 | $3,094 | $135 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 19 | $1,876 | $85 |
| X-ray of knee, 3 views | 30 | $1,270 | $33 |
| X-ray of hip, 2-3 views | 20 | $784 | $39 |
| X-ray of shoulder, minimum of 2 views | 17 | $647 | $34 |
| Injection, methylprednisolone acetate, 40 mg | 47 | $548 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 61 | $422 | None |
2021: 14 services
| Short return visit (20+ min) | 122 | $15,054 | $82 |
| New patient visit (30+ min) | 69 | $6,293 | $91 |
| Aspiration and/or injection of fluid from large joint | 80 | $6,209 | $57 |
| Return visit (30+ min) | 41 | $5,035 | $117 |
| Mri scan of leg joint without contrast | 25 | $4,282 | $171 |
| X-ray of knee, 3 views | 45 | $1,948 | $37 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 13 | $1,299 | $100 |
| X-ray of hip, 2-3 views | 26 | $1,160 | $45 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $835 | $64 |
| X-ray of shoulder, minimum of 2 views | 22 | $704 | $24 |
| Short return visit | 12 | $651 | $43 |
| Injection, methylprednisolone acetate, 40 mg | 65 | $586 | None |
| Injection, methylprednisolone acetate, 80 mg | 14 | $128 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $96 | None |
2020: 11 services
| Short return visit (20+ min) | 108 | $8,342 | $60 |
| Return visit (30+ min) | 52 | $4,508 | $87 |
| New patient visit (30+ min) | 49 | $4,383 | $89 |
| Aspiration and/or injection of fluid from large joint | 45 | $2,619 | $48 |
| Mri scan of leg joint without contrast | 11 | $2,045 | $157 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $983 | $66 |
| X-ray of knee, 3 views | 22 | $766 | $32 |
| X-ray of hip, 2-3 views | 16 | $742 | $46 |
| X-ray of shoulder, minimum of 2 views | 13 | $582 | $31 |
| Injection, methylprednisolone acetate, 40 mg | 25 | $177 | None |
| Injection, methylprednisolone acetate, 80 mg | 15 | $129 | None |
2019: 14 services
| Short return visit (20+ min) | 170 | $14,667 | $67 |
| Return visit (30+ min) | 91 | $8,798 | $96 |
| New patient visit (30+ min) | 76 | $6,899 | $91 |
| Aspiration and/or injection of fluid from large joint | 68 | $4,558 | $55 |
| X-ray of knee, 3 views | 29 | $1,021 | $35 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $848 | $65 |
| X-ray of shoulder, minimum of 2 views | 28 | $836 | $29 |
| X-ray of hip, 2-3 views | 19 | $745 | $39 |
| X-ray of knee, 1-2 views | 15 | $690 | $33 |
| X-ray of hip, 1 view | 17 | $593 | $31 |
| Short return visit | 14 | $568 | $41 |
| Injection, methylprednisolone acetate, 80 mg | 37 | $416 | None |
| X-ray of ankle, minimum of 3 views | 12 | $407 | $31 |
| Injection, methylprednisolone acetate, 40 mg | 28 | $165 | None |
2018: 16 services
| Short return visit (20+ min) | 200 | $15,684 | $61 |
| New patient visit (30+ min) | 108 | $9,836 | $91 |
| Aspiration and/or injection of fluid from large joint | 118 | $7,799 | $54 |
| Return visit (30+ min) | 79 | $7,697 | $92 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 12 | $3,080 | None |
| Mri scan of leg joint without contrast | 14 | $2,714 | $170 |
| X-ray of knee, 3 views | 59 | $2,088 | $34 |
| X-ray of hip, 2-3 views | 27 | $1,209 | $42 |
| X-ray of shoulder, minimum of 2 views | 29 | $966 | $29 |
| Short return visit | 19 | $755 | $40 |
| X-ray of ankle, minimum of 3 views | 11 | $618 | $31 |
| Injection, methylprednisolone acetate, 80 mg | 48 | $617 | None |
| X-ray of knee, 1-2 views | 13 | $500 | $29 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $374 | $34 |
| Injection, methylprednisolone acetate, 40 mg | 46 | $271 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $94 | None |
2017: 16 services
| Short return visit (20+ min) | 208 | $17,563 | $64 |
| Aspiration and/or injection of fluid from large joint | 122 | $9,240 | $54 |
| Return visit (30+ min) | 80 | $8,255 | $97 |
| New patient visit (30+ min) | 84 | $7,671 | $91 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 19 | $4,345 | None |
| X-ray of knee, 3 views | 49 | $1,858 | $35 |
| X-ray of hip, 2-3 views | 25 | $1,018 | $41 |
| Short return visit | 20 | $927 | $39 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $711 | $65 |
| Injection, methylprednisolone acetate, 80 mg | 50 | $581 | None |
| X-ray of shoulder, minimum of 2 views | 18 | $499 | $26 |
| X-ray of shoulder, 1 view | 14 | $486 | $22 |
| X-ray of wrist, 2 views | 12 | $443 | $30 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $391 | $36 |
| Injection, methylprednisolone acetate, 40 mg | 56 | $310 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 24 | $114 | None |
2016: 12 services
| Short return visit (20+ min) | 168 | $13,561 | $63 |
| Return visit (30+ min) | 89 | $9,183 | $94 |
| New patient visit (30+ min) | 81 | $7,230 | $89 |
| Aspiration and/or injection of fluid from large joint | 93 | $6,396 | $57 |
| X-ray of knee, 3 views | 42 | $1,595 | $36 |
| Short return visit | 32 | $1,566 | $41 |
| X-ray of shoulder, minimum of 2 views | 32 | $977 | $27 |
| X-ray of hip, 2-3 views | 21 | $898 | $41 |
| X-ray of pelvis, 1-2 views | 17 | $527 | $31 |
| X-ray of knee, 1-2 views | 12 | $416 | $30 |
| Injection, methylprednisolone acetate, 80 mg | 36 | $308 | None |
| Injection, methylprednisolone acetate, 40 mg | 51 | $240 | None |
2015: 12 services
| Return visit (30+ min) | 111 | $12,663 | $100 |
| Short return visit (20+ min) | 90 | $7,886 | $67 |
| New patient visit (30+ min) | 80 | $7,489 | $94 |
| Aspiration and/or injection of fluid from large joint | 73 | $4,968 | $57 |
| X-ray of knee, 3 views | 37 | $1,418 | $34 |
| X-ray of ankle, minimum of 3 views | 20 | $889 | $32 |
| X-ray of shoulder, minimum of 2 views | 30 | $842 | $26 |
| Short return visit | 12 | $509 | $42 |
| X-ray of pelvis, 1-2 views | 19 | $509 | $27 |
| X-ray of hip on one side of body, 1 view | 18 | $500 | $26 |
| Injection, methylprednisolone acetate, 80 mg | 40 | $274 | None |
| Injection, methylprednisolone acetate, 40 mg | 37 | $123 | None |
2014: 15 services
| Return visit (30+ min) | 120 | $12,382 | $92 |
| Short return visit (20+ min) | 105 | $10,133 | $64 |
| New patient visit (30+ min) | 90 | $8,236 | $92 |
| Aspiration and/or injection of fluid from large joint | 71 | $5,272 | $52 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,071 | $181 |
| X-ray of knee, 3 views | 48 | $1,989 | $38 |
| X-ray of shoulder, minimum of 2 views | 35 | $1,436 | $31 |
| Short return visit | 25 | $1,055 | $36 |
| X-ray of ankle, minimum of 3 views | 16 | $934 | $33 |
| X-ray of pelvis, 1-2 views | 24 | $667 | $28 |
| X-ray of foot, minimum of 3 views | 13 | $525 | $29 |
| X-ray of lower and sacral spine, 2-3 views | 13 | $480 | $37 |
| X-ray of hip on one side of body, 1 view | 16 | $471 | $28 |
| Injection, methylprednisolone acetate, 80 mg | 36 | $201 | None |
| Injection, methylprednisolone acetate, 40 mg | 34 | $92 | None |
2013: 11 services
| New patient visit (30+ min) | 105 | $9,754 | $93 |
| Short return visit (20+ min) | 110 | $8,841 | $59 |
| Return visit (30+ min) | 74 | $7,011 | $92 |
| Aspiration and/or injection of fluid from large joint | 91 | $6,072 | $55 |
| X-ray of knee, 3 views | 30 | $1,302 | $38 |
| X-ray of shoulder, minimum of 2 views | 27 | $939 | $30 |
| X-ray of hip on one side of body, 1 view | 14 | $396 | $28 |
| X-ray of pelvis, 1-2 views | 14 | $388 | $28 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 22 | $239 | None |
| Injection, methylprednisolone acetate, 80 mg | 40 | $222 | None |
| Injection, methylprednisolone acetate, 40 mg | 25 | $60 | None |
Drugs they prescribed that Part D paid
$322
Pharmacies billed $322 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
40 generic and fewer than 11 brand-name prescriptions · $322 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Diclofenac | 20 | $142 | $7 |
Year by year
| 2024 | 41 | 22 | None | None | $322 |
| 2023 | 50 | 26 | 28% (14) | 0% | $533 |
| 2022 | 103 | 46 | 18% (19) | None | $1,258 |
| 2021 | 107 | 48 | 36% (38) | None | $1,341 |
| 2020 | 70 | 33 | 19% (13) | None | $1,216 |
| 2019 | 78 | 46 | 36% (28) | None | $3,043 |
| 2018 | 84 | 47 | 44% (37) | None | $1,078 |
| 2017 | 87 | 50 | 36% (31) | None | $1,530 |
| 2016 | 89 | 56 | 35% (31) | None | $1,470 |
| 2015 | 123 | 68 | 60% (74) | None | $3,718 |
| 2014 | 137 | 78 | 42% (57) | None | $8,738 |
| 2013 | 107 | 64 | 62% (66) | None | $3,962 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Diclofenac | 16 | $249 | $16 |
2022: 2 drugs
| Diclofenac | 46 | $685 | $15 |
| Hydrocodone-Acetaminophen | 16 | $83 | $5 |
2021: 2 drugs
| Diclofenac | 36 | $368 | $10 |
| Hydrocodone-Acetaminophen | 35 | $214 | $6 |
2020: 2 drugs
| Diclofenac | 21 | $291 | $14 |
| Gabapentin | 14 | $45 | $3 |
2019: 1 drug
| Hydrocodone-Acetaminophen | 15 | $92 | $6 |
2018: 2 drugs
| Hydrocodone-Acetaminophen | 21 | $305 | $15 |
| Diclofenac | 18 | $249 | $14 |
2017: 2 drugs
| Diclofenac | 27 | $402 | $15 |
| Hydrocodone-Acetaminophen | 19 | $330 | $17 |
2016: 3 drugs
| Diclofenac | 25 | $383 | $15 |
| Hydrocodone-Acetaminophen | 20 | $297 | $15 |
| Meloxicam | 13 | $60 | $5 |
2015: 2 drugs
| Oxycodone-Acetaminophen | 21 | $693 | $33 |
| Hydrocodone-Acetaminophen | 41 | $570 | $14 |
2014: 4 drugs
| Doxepin | 14 | $2,856 | $204 |
| Oxycodone-Acetaminophen | 21 | $559 | $27 |
| Diclofenac | 18 | $466 | $26 |
| Hydrocodone-Acetaminophen | 27 | $445 | $16 |
2013: 2 drugs
| Hydrocodone-Acetaminophen | 47 | $686 | $15 |
| Naproxen | 14 | $117 | $8 |
Money from drug and device companies
$30 in 2025
| 2025 | 1 | 1 | None | $30 |
| 2024 | 1 | 1 | None | $32 |
| 2023 | 2 | 2 | None | $187 |
| 2022 | 1 | 1 | None | $18 |
| 2021 | 2 | 2 | None | $43 |
| 2019 | 4 | 4 | None | $405 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Evolution Surgical | None | $30 | 1 payment
|
See the published payment
| Evolution Surgical | Meals · 2025-09-23 | None | $30 |
See earlier years (2024, 2023, 2022, 2021, 2019)
2024: $32
| Bioventus | Durolane | $32 | 1 payment
|
2023: $187
| Miach Orthopaedics | None | $138 | 1 payment
|
| DePuy Synthes Sales | Bristow Latarjet | $49 | 1 payment
|
2022: $18
| Bioventus | Durolane | $18 | 1 payment
|
2021: $43
| Pacira Therapeutics | Zilretta | $26 | 1 payment
|
| DePuy Synthes Sales | Truespan Orthocord | $17 | 1 payment
|
2019: $405
| Stryker | Mako | $150 | 1 payment
|
| Wright Medical Technology | Perform Glenoid | $123 | 1 payment
|
| Catalyst OrthoScience | Catalyst Total Csr | $102 | 1 payment
|
| DePuy Synthes Sales | Dynacord | $31 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1548452782
- Licence
- CA A106438California A106438: Current · expires 2026-11-30
- Trained
- Stanford University School of Medicine, 2004 · 22 years ago
- Group
- California Pacific Orthopaedics and Sports Medicine A Medical Corporat · Regents of the University of California - UCSF
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207XX0005X (207XX0005X)
- Mailing address
- 3838 California St Rm 715, San Francisco, CA, 94118
- NPI first listed
- 2007-08-13
- NPI last updated
- 2022-08-01
- NPI record certified
- 2021-02-04
This is when the NPI record was last certified, not a medical board exam.